Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Assets Average: 2011-2020

Historic Assets Average for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2020 value amounting to $1.5 billion.

  • Neurocrine Biosciences' Assets Average rose 31.66% to $2.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 billion, marking a year-over-year increase of 31.66%. This contributed to the annual value of $1.5 billion for FY2020, which is 32.25% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Assets Average stood at $1.5 billion for FY2020, which was up 32.25% from $1.1 billion recorded in FY2019.
  • Neurocrine Biosciences' 5-year Assets Average high stood at $1.5 billion for FY2020, and its period low was $419.9 million during FY2016.
  • Its 3-year average for Assets Average is $1.2 billion, with a median of $1.1 billion in 2019.
  • Data for Neurocrine Biosciences' Assets Average shows a peak YoY surged of 53.11% (in 2018) over the last 5 years.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Assets Average stood at $419.9 million in 2016, then soared by 40.82% to $591.3 million in 2017, then surged by 53.11% to $905.4 million in 2018, then increased by 26.97% to $1.1 billion in 2019, then skyrocketed by 32.25% to $1.5 billion in 2020.